ArticleAmerican journal of cancer research2021

Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.

Wei-Fan Hsu et al.PubMed ↗Full text ↗

No numbers read from the abstract.